Table 3 The relationship between DANCR expression and different parameters in AML
lncRNA DANCR | ||||||
|---|---|---|---|---|---|---|
Variable | Low (≤ 0.64) (n = 30) | High (> 0.64) (n = 30) | χ2 | p | ||
No | % | No | % | |||
Age (/years) | ||||||
18 – 30 | 9 | 30.0 | 9 | 30.0 | 0.889 | 0.641 |
> 30 – 45 | 14 | 46.7 | 11 | 36.7 | ||
> 45 – 65 | 7 | 23.3 | 10 | 33.3 | ||
Sex | ||||||
Male | 12 | 40.0 | 12 | 40.0 | 0.000 | 1.000 |
Female | 18 | 60.0 | 18 | 60.0 | ||
FAB subtypes | ||||||
M0 | 0 | 0.0 | 2 | 6.7 | 15.510* | MCp = 0.001* |
M1 | 4 | 13.3 | 16 | 53.3 | ||
M2 | 2 | 6.7 | 2 | 6.7 | ||
M4 | 8 | 26.7 | 5 | 16.7 | ||
M5 | 16 | 53.3 | 5 | 16.7 | ||
Cytogenetics | ||||||
Normal | 16 | 53.3 | 12 | 40.0 | 1.071 | 0.301 |
Abnormal cytogenetics | 6 | 20.0 | 7 | 23.3 | 0.098 | 0.754 |
Undefined a | 8 | 26.7 | 11 | 36.7 | 0.693 | 0.405 |
Response to treatment | ||||||
Partial remission | 2 | 6.7 | 1 | 3.3 | 0.351 | FEp = 1.000 |
Complete remission | 5 | 16.7 | 7 | 23.3 | 0.417 | 0.519 |
Refractory | 11 | 36.7 | 8 | 26.7 | 0.693 | 0.405 |
Died | 9 | 30.0 | 10 | 33.3 | 0.077 | 0.781 |
Lost in Follow-up | 3 | 10.0 | 4 | 13.3 | 0.162 | FEp = 1.000 |